1-3 of 3
Li Li, Ph.D.
Close
Sort by
Journal Articles

EB10, an Anti-FLT3 Monoclonal Antibody, Prolongs Survival and Reduces NOD/SCID Engraftment of AML Cell Lines and Primary Blasts.

Obdulio Piloto, B.S., Mark Levis, M.D./Ph.D., Li Li, Ph.D., Bao Nguyen, M.S., Kyu-Tae Kim, Ph.D., David Huso, Ph.D., Yiwen Li, Ph.D., Hongli Li, Ph.D., Mei-Nai Wang, Ph.D., Larry Witte, Ph.D., Daniel J. Hicklin, Ph.D., Donald Small, M.D./Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2534.
https://doi.org/10.1182/blood.V104.11.2534.2534
Published: 2004
Journal Articles

EB10, an Anti-FLT3 Monoclonal Antibody, Selectively Targets ALL Cell Lines and Primary ALL Blasts without Interfering with Normal Hematopoiesis.

Obdulio Piloto, B.S., Patrick Brown, M.D., Li Li, Ph.D., Bao Nguyen, M.S., Kyu-Tae Kim, Ph.D., David Huso, Ph.D., Yiwen Li, Ph.D., Hongli Li, Ph.D., Mei-Nai Wang, Ph.D., Larry Witte, Ph.D., Daniel J. Hicklin, Ph.D., Donald Small, M.D./Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2744.
https://doi.org/10.1182/blood.V104.11.2744.2744
Published: 2004
Journal Articles

FLT3/ITD Expression Increases Expansion, Survival and Entry into Cell Cycle of Human Hematopoietic Stem Cells.

Li Li, Ph.D., Obdulio Piloto, B.S., Kyu-Tae Kim, Ph.D., Zhaohui Ye, M.S., Bao Nguyen, M.S., Xiaobing Yu, M.D., Ph.D., Mark Levis, M.D., Ph.D., Linzhao Cheng, Ph.D., Donald Small, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 484.
https://doi.org/10.1182/blood.V104.11.484.484
Published: 2004